New Key Statistics Module, Z-Score and F-Score
NAS:STRO Key Ratios
| Market Cap $ M | 365.15 |
| Enterprise Value $ M | -21.61 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 2.48 |
| Price/Sales | 1.73 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 169.00 |
| EPS (TTM) $ | -1.83 |
| Beneish M-Score | -2 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | 19.70 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | 0.30 |
| EV-to-EBITDA | 0.34 |
| PEG | -- |
| Shares Outstanding M | 81.96 |
| Net Margin (%) | -73.48 |
| Operating Margin % | -62.67 |
| Pre-tax Margin (%) | -63.06 |
| Quick Ratio | 3.41 |
| Current Ratio | 3.41 |
| ROA % (ttm) | -27.54 |
| ROE % (ttm) | -93.30 |
| ROIC % (ttm) | -116.36 |
| Dividend Yield % | -- |
| Altman Z-Score | -0.60 |
STRO Number of Guru Trades
STRO Volume of Guru Trades
Gurus Latest Trades with NAS:STRO
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:STRO is held by these investors
Total 1
Sutro Biopharma Inc Insider Transactions
No Available Data
News about NAS:STRO
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers